ALBANO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 9.343
EU - Europa 4.013
AS - Asia 689
AF - Africa 9
SA - Sud America 8
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.066
Nazione #
US - Stati Uniti d'America 9.335
DE - Germania 1.833
SE - Svezia 628
CN - Cina 535
GB - Regno Unito 425
RU - Federazione Russa 419
IT - Italia 278
FI - Finlandia 128
UA - Ucraina 123
FR - Francia 75
VN - Vietnam 52
IN - India 41
BE - Belgio 34
IE - Irlanda 31
PL - Polonia 10
RO - Romania 8
TH - Thailandia 7
HK - Hong Kong 6
IQ - Iraq 6
JP - Giappone 6
BR - Brasile 5
KR - Corea 5
IR - Iran 4
NL - Olanda 4
TR - Turchia 4
CA - Canada 3
ES - Italia 3
JO - Giordania 3
MX - Messico 3
SG - Singapore 3
AU - Australia 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
KZ - Kazakistan 2
SA - Arabia Saudita 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ML - Mali 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
Totale 14.066
Città #
Fairfield 1.600
Woodbridge 929
Chandler 838
Ashburn 776
Houston 728
Seattle 687
Cambridge 541
Nyköping 524
Wilmington 475
Ann Arbor 359
Jacksonville 306
New York 278
Lawrence 183
Roxbury 176
Beijing 173
Nanjing 123
Bari 119
Des Moines 106
Princeton 85
Brooklyn 71
Inglewood 65
San Diego 64
Dong Ket 50
Redwood City 42
Boardman 41
Nanchang 38
Paris 38
Brussels 34
London 34
Dublin 29
Shenyang 28
Dearborn 27
Tianjin 26
Hebei 25
Jiaxing 25
Los Angeles 24
Changsha 23
Helsinki 22
Pune 22
Marseille 21
Falls Church 16
Ningbo 11
Rome 11
Jinan 8
Washington 8
Hefei 7
Kilburn 7
Norwalk 7
Guangzhou 6
Hong Kong 6
Hounslow 6
Bologna 5
Chicago 5
Imbersago 5
Kunming 5
Taizhou 5
Zhengzhou 5
Bisceglie 4
Chiswick 4
Grafing 4
Indiana 4
Nürnberg 4
Prescot 4
Tokyo 4
Atlanta 3
Bangkok 3
Bitonto 3
Casamassima 3
Erbil 3
Fuzhou 3
Milan 3
New Bedfont 3
Padova 3
Trani 3
Acton 2
Addis Ababa 2
Arbil 2
Augusta 2
Boydton 2
Brindisi 2
Budapest 2
Ferrara 2
Foggia 2
Greenwich 2
Hanoi 2
Istanbul 2
Kraków 2
Molfetta 2
New Delhi 2
Peschiera Borromeo 2
Pulsano 2
San Mateo 2
Sao Jeronimo da Serra 2
Shanghai 2
Taipei 2
Tappahannock 2
Terni 2
Zagreb 2
Ahmedabad 1
Almaty 1
Totale 9.986
Nome #
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 158
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 157
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 151
Monosomal karyotype in myeloid neoplasias: a literature review 149
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 145
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 135
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia 132
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 132
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 130
A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma 130
Concomitant occurrence of BCR-ABL and JAK2V617F mutation 128
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 128
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 128
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 128
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene 126
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 122
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 119
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 117
Similar mechanisms formed ring markers containing chromosome 12 pericentromeric region in two patients with therapy-related acute myeloid leukemia 117
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 117
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 117
Decreased TET2 gene expression during chronic myeloid leukemia progression 116
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 116
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 116
null 115
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 115
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma 114
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 114
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 112
Iron chelation therapy induces hematological response in transfusion dependent patient with myeloid malignancies 112
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy 112
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 111
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 110
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 110
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 110
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 110
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 110
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 109
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 109
Differences among young adults, adults, and elderly chronic myeloid leukemia patients. 109
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 108
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 107
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 107
null 107
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 104
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile. 103
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 103
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP 102
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. 102
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia 101
null 100
Bone marrow ectopic expression of a non-coding RNA in childhood T-cell acute lymphoblastic leukemia with a novel t(2;11)(q11.2;p15.1) translocation 100
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial 100
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a PH-positive chronic myeloid leukemia 99
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 99
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto 99
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 99
Extramedullary disease in acute promyelocytic leukemia: two-in-one disease. 98
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 98
Retinal abnormalities in newly diagnosed adult acute myeloid leukemia 98
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 97
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 96
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 96
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 96
Concomitant tetrasomy 3q and trisomy 18 in CD5- CD13+ chronic lymphocytic leukemia 95
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 95
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 95
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 94
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 94
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 94
null 93
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 93
Non-treatment-related chronic myeloid leukemia as a second malignancy 92
null 92
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 92
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia 92
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 89
SETBP1 dysregulation in congenital disorders and myeloid neoplasms 89
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 88
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 88
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 87
null 87
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 87
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients 87
MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9) 86
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale 86
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 86
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 86
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 86
Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML 85
Characterization of der(9) deletions in CML patients 84
Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis 84
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 83
Molecular cytogenetics characterization of a novel translocation involving chromosomes 17 and 19 in a Ph+ adult acute lymphoblastic leukemia 82
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 82
Late-appearing pseudocentric fission event during chronic myeloid leukemia progression 81
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 81
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 81
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 80
Upregulation of MEL1 and FLJ42875 genes by position effect resulting from a t(1;2)(p36;p21) occurring during evolution of chronic myelomonocytic leukemia 80
Totale 10.471
Categoria #
all - tutte 55.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019927 0 0 0 0 0 0 0 0 0 0 453 474
2019/20203.683 432 163 206 401 367 239 354 345 427 285 246 218
2020/20212.524 132 403 173 256 243 210 118 303 128 255 141 162
2021/20221.448 134 139 19 36 68 136 70 62 124 130 227 303
2022/20232.261 311 311 158 153 228 318 38 273 350 11 49 61
2023/2024955 80 140 56 58 106 411 25 43 6 29 1 0
Totale 14.570